NCT06586749 Effect of Nurse-Led Education and Tele-Interventions on Reducing Surgical Site Infections in Patients After Coronary Artery Bypass Surgery: a Clinical Trial
| NCT ID | NCT06586749 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hellenic Mediterranean University |
| Condition | Surgical Site Infection |
| Study Type | INTERVENTIONAL |
| Enrollment | 220 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2025-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 220 participants in total. It began in 2024-03-01 with a primary completion date of 2025-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to determine if nurse-led education and tele-interventions can reduce the incidence of surgical wound infections in patients after coronary artery bypass surgery. The main questions it aims to answer are: * Can nurse-led education reduce the rate of surgical wound infections after coronary artery bypass surgery? * Does the addition of tele-interventions further decrease the incidence of these infections compared to standard care? Researchers will compare three groups: * Group A: Standard postoperative care * Group B: Nurse-led patient education * Group C: Nurse-led patient education plus tele-interventions Participants will: * Receive standard care, nurse-led education, or nurse-led education with tele-interventions * Having regular follow-up as per group assignment * Monitor and report infection during the study period
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Patients who have undergone CABG with median sternotomy * Proficiency in reading and writing in Greek * Patients who provide written informed consent for participation in the study * Patients who have access to a mobile phone and know how to use it * Patients without difficulties in vision, speech, or hearing * Patients at intermediate or high risk for developing surgical site infections, based on their scores in the risk stratification models described below Exclusion Criteria: * History of psychiatric illness, recent history of alcohol and/or substance abuse, dementia, and Alzheimer's disease * Presence of an active infection within 2 weeks prior to the surgical procedure * Preoperative hospitalization \> 2 days * Concurrent surgery on the aorta or heart valves * Urgent or emergency nature of the surgical procedure * Re-sternotomy aimed at surgical re-exploration of bleeding or implementation of cardiopulmonary resuscitation (CPR) in cases of cardiac arrest * Patients in whom the sternum has not been closed after the completion of the surgical procedure and who are transferred to the cardiothoracic unit without sternum closure * Active endocarditis * Life expectancy \< 6 months * Lack of a smartphone
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06586749 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Surgical Site Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06586749 currently recruiting?
Yes, NCT06586749 is actively recruiting participants. Contact the research team at kongiakoumidakis@hmu.gr for enrollment information.
Where is the NCT06586749 trial being conducted?
This trial is being conducted at Heraklion, Greece.
Who is sponsoring the NCT06586749 clinical trial?
NCT06586749 is sponsored by Hellenic Mediterranean University. The trial plans to enroll 220 participants.